Usefulness of gallium-67 citrate scanning in testicular seminoma

Journal Article · Thu Oct 01 00:00:00 EDT 1987 · Clin. Nucl. Med.; (United States)

DOI:https://doi.org/10.1097/00003072-198710000-00014· OSTI ID:5652473

Willan, B D; Penney, H; Castor, W R; McGowan, D G

An analysis of 77 consecutive patients with a histologic diagnosis of seminoma testis, assessed and treated at the Cross Cancer Institute between 1977 and 1982, is presented. Ga-67 citrate was first used in the assessment of patients with malignant testicular tumors in 1973. Following three years of study that supported the observation of the gallium-avid nature of seminoma, gallium scans became routine in the initial staging assessment and were used also when recurrence was suspected. From 1977 through 1982, 72 patients with biopsy-proven seminoma testis were assessed initially for extent of disease by Ga-67 scanning. Comparison with intravenous pyelography and bipedal lymphography was possible for accuracy of tumor assessment. The scan sensitivity was 83%, and the specificity was 95%. During the same period, gallium was studied in nonseminomatous testicular tumors but the results were disappointing and its use was discontinued. The gallium-avid nature of seminoma testis may be useful in determining the extent of disease.

• Research Organization: Cross Cancer Institute, Edmonton, Alberta
• OSTI ID: 5652473
• Journal Information: Clin. Nucl. Med.; (United States), Vol. 12:10
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
GALLIUM 67
DIAGNOSTIC USES
NEOPLASMS
DIAGNOSIS
TESTES
RADIOISOTOPE SCANNING
PATIENTS
SENSITIVITY ANALYSIS
BETA DECAY RADIOISOTOPES
BODY
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
GALLIUM ISOTOPES
GONADS
INTERMEDIATE MASS NUCLEI
ISOTOPES
MALE GENITALS
NUCLEI
ODD-EVEN NUCLEI
ORGANS
RADIOISOTOPES
USES
550601* - Medicine- Unsealed Radionuclides in Diagnostics